BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiota S, Matsunari O, Watada M, Yamaoka Y. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol. 2010;5:1885-1893. [PMID: 21155667 DOI: 10.2217/fmb.10.135] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Shiota S, Yamaoka Y. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Biomark Med 2014;8:1127-37. [PMID: 25402582 DOI: 10.2217/bmm.14.72] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
2 Douraghi M, Goudarzi H, Nateghi Rostami M, Nikmanesh B. Immune responses to Helicobacter pylori infection in children with intellectual disabilities. Research in Developmental Disabilities 2012;33:663-9. [DOI: 10.1016/j.ridd.2011.11.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Yuan L, Zhao JB, Zhou YL, Qi YB, Guo QY, Zhang HH, Khan MN, Lan L, Jia CH, Zhang YR, Ding SZ. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol 2020; 26(25): 3673-3685 [PMID: 32742135 DOI: 10.3748/wjg.v26.i25.3673] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bakhti SZ, Latifi-navid S, Gholizade Tobnagh S, Yazdanbod K, Yazdanbod A. Which genotype of Helicobacter pylori—cagA or cagE—Is better associated with gastric Cancer risk? Lessons from an extremely high-risk area in Iran. Infection, Genetics and Evolution 2020;85:104431. [DOI: 10.1016/j.meegid.2020.104431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Luzza F, Suraci E, Larussa T, Leone I, Imeneo M. High exposure, spontaneous clearance, and low incidence of active Helicobacter pylori infection: the Sorbo San Basile study. Helicobacter. 2014;19:296-305. [PMID: 24758553 DOI: 10.1111/hel.12133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
6 Magat EM, Balanag GA, CariÑo AM, Fellizar A, Ortin TS, Guevarra L Jr, Albano PM. Clostridioides difficile antibody response of colorectal cancer patients versus clinically healthy individuals. Biosci Microbiota Food Health 2020;39:123-7. [PMID: 32775130 DOI: 10.12938/bmfh.2020-010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther 2018;47:494-503. [PMID: 29243850 DOI: 10.1111/apt.14471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
8 Uchida T, Miftahussurur M, Pittayanon R, Vilaichone RK, Wisedopas N, Ratanachu-Ek T, Kishida T, Moriyama M, Yamaoka Y, Mahachai V. Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype. PLoS One. 2015;10:e0136775. [PMID: 26355839 DOI: 10.1371/journal.pone.0136775] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
9 Miftahussurur M, Yamaoka Y. Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int 2016;2016:4819423. [PMID: 26904678 DOI: 10.1155/2016/4819423] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
10 Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis. 2013;14:341-349. [PMID: 23452293 DOI: 10.1111/1751-2980.12054] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 10.0] [Reference Citation Analysis]
11 Suharsono H, Wibawa DN, Muttaqin Z, Agustina KK. Structure of cytotoxic associated antigen A protein of Helicobacter pylori from Bali and Lombok isolates of Indonesia. Vet World 2020;13:1319-26. [PMID: 32848306 DOI: 10.14202/vetworld.2020.1319-1326] [Reference Citation Analysis]
12 Epplein M, Zheng W, Xiang YB, Peek RM, Li H, Correa P, Gao J, Michel A, Pawlita M, Cai Q. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev. 2012;21:2185-2192. [PMID: 23035179 DOI: 10.1158/1055-9965.epi-12-0792-t] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
13 Rasheed F, Campbell BJ, Alfizah H, Varro A, Zahra R, Yamaoka Y, Pritchard DM. Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. Helicobacter. 2014;19:387-399. [PMID: 24827414 DOI: 10.1111/hel.12142] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
14 Zhang YW, Eom SY, Yim DH, Song YJ, Yun HY, Park JS, Youn SJ, Kim BS, Kim YD, Kim H. Evaluation of the relationship between dietary factors, CagA-positive Helicobacter pylori infection, and RUNX3 promoter hypermethylation in gastric cancer tissue. World J Gastroenterol 2013; 19(11): 1778-1787 [PMID: 23555166 DOI: 10.3748/wjg.v19.i11.1778] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
15 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
16 Su YL, Huang HL, Huang BS, Chen PC, Chen CS, Wang HL, Lin PH, Chieh MS, Wu JJ, Yang JC, Chow LP. Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer. Sci Rep 2016;6:36442. [PMID: 27819260 DOI: 10.1038/srep36442] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
17 El Khadir M, Boukhris SA, Zahir SO, Benajah DA, Ibrahimi SA, Chbani L, El Abkari M, Bennani B. CagE, cagA and cagA 3' region polymorphism of Helicobacter pylori and their association with the intra-gastric diseases in Moroccan population. Diagn Microbiol Infect Dis 2021;100:115372. [PMID: 33813354 DOI: 10.1016/j.diagmicrobio.2021.115372] [Reference Citation Analysis]
18 Shiota S, Mahachai V, Vilaichone RK, Ratanachu-ek T, Tshering L, Uchida T, Matsunari O, Yamaoka Y. Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol. 2013;62:1571-1578. [PMID: 23831768 DOI: 10.1099/jmm.0.060905-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
19 Flores-Luna L, Camorlinga-Ponce M, Hernandez-Suarez G, Kasamatsu E, Martínez ME, Murillo R, Lazcano E, Torres J. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries. Cancer Causes Control. 2013;24:241-248. [PMID: 23184121 DOI: 10.1007/s10552-012-0106-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
20 Shiota S, Murakami K, Okimoto T, Kodama M, Yamaoka Y. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol 2014;29:67-73. [PMID: 24033876 DOI: 10.1111/jgh.12359] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
21 Syam AF, Waskito LA, Rezkitha YAA, Simamora RM, Yusuf F, Danchi KE, Bakry AF, Arnelis, Mulya E, Siregar GA, Sugihartono T, Maulahela H, Doohan D, Miftahussurur M, Yamaoka Y. Helicobacter pylori in the Indonesian Malay's descendants might be imported from other ethnicities. Gut Pathog 2021;13:36. [PMID: 34088343 DOI: 10.1186/s13099-021-00432-6] [Reference Citation Analysis]
22 Islam MM, Poly TN, Walther BA, Lin MC, Li YJ. Artificial Intelligence in Gastric Cancer: Identifying Gastric Cancer Using Endoscopic Images with Convolutional Neural Network. Cancers (Basel) 2021;13:5253. [PMID: 34771416 DOI: 10.3390/cancers13215253] [Reference Citation Analysis]
23 Tian W, Jia Y, Yuan K, Huang L, Nadolny C, Dong X, Ren X, Liu J. Serum Antibody Against Helicobacter pylori FlaA and Risk of Gastric Cancer. Helicobacter 2014;19:9-16. [DOI: 10.1111/hel.12095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Karakus C, Ulupinar Z, Akbas F, Yazici D. Detection of Anti-CagA Antibodies in Sera of Helicobacter pylori-Infected Patients Using an Immunochromatographic Test Strip. J Chromatogr Sci 2020;58:217-22. [PMID: 31812997 DOI: 10.1093/chromsci/bmz093] [Reference Citation Analysis]
25 Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. Toxins (Basel). 2018;10:pii: E163. [PMID: 29671784 DOI: 10.3390/toxins10040163] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 14.3] [Reference Citation Analysis]
26 Li H, Zhang B, Hu X, Dong Y, Fan Q, Guo F, Ren X, Zhou H, Tian W, Zhao Y. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer. Oncotarget 2016;7:22397-408. [PMID: 26968951 DOI: 10.18632/oncotarget.7981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
27 Delgado P, Peñaranda N, Zamora MA, del Pilar Delgado M, Bohorquez E, Castro H, Barrios AFG, Jaramillo C. Computational approaches for evaluating the effect of sequence variations and the intrinsically disordered C-terminal region of the Helicobacter pylori CagA protein on the interaction with tyrosine kinase Src. J Mol Model 2014;20. [DOI: 10.1007/s00894-014-2406-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Sekar D, Krishnan R, Thirugnanasambantham K, Rajasekaran B, Islam VI, Sekar P. Significance of microRNA 21 in gastric cancer. Clin Res Hepatol Gastroenterol 2016;40:538-45. [PMID: 27179559 DOI: 10.1016/j.clinre.2016.02.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
29 Akada J, Okuda M, Hiramoto N, Kitagawa T, Zhang X, Kamei S, Ito A, Nakamura M, Uchida T, Hiwatani T. Proteomic characterization of Helicobacter pylori CagA antigen recognized by child serum antibodies and its epitope mapping by peptide array. PLoS One. 2014;9:e104611. [PMID: 25141238 DOI: 10.1371/journal.pone.0104611] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
30 Chmiela M, Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J Gastroenterol 2017; 23(22): 3964-3977 [PMID: 28652651 DOI: 10.3748/wjg.v23.i22.3964] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
31 Osaki T, Konno M, Yonezawa H, Hojo F, Zaman C, Takahashi M, Fujiwara S, Kamiya S. Analysis of intra-familial transmission of Helicobacter pylori in Japanese families. Journal of Medical Microbiology 2015;64:67-73. [DOI: 10.1099/jmm.0.080507-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
32 Zeng Z, Wang J, Zhao L, Hu P, Zhang H, Tang X, He D, Tang S, Zeng Z. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis. PLoS One. 2013;8:e73278. [PMID: 24023850 DOI: 10.1371/journal.pone.0073278] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
33 Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015;20:239-51. [PMID: 25728540 DOI: 10.1111/hel.12200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
34 Miftahussurur M, Waskito LA, Fauzia KA, Mahmudah I, Doohan D, Adnyana IK, Khomsan A, Ratnasari N, Rezkitha YAA. Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence? Gut Liver 2021;15:653-65. [PMID: 32616679 DOI: 10.5009/gnl20019] [Reference Citation Analysis]
35 Negi S, Singh H, Mukhopadhyay A. Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study. PLoS One 2017;12:e0180518. [PMID: 28678867 DOI: 10.1371/journal.pone.0180518] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
36 Khatoon J, Prasad KN, Prakash Rai R, Ghoshal UC, Krishnani N. Association of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer. Br J Biomed Sci. 2017;74:121-126. [PMID: 28571523 DOI: 10.1080/09674845.2017.1278887] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
37 Na YJ, Shim K, Joo YH, Kim S, Jung H, Jung S, Cho MS. RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma. Korean J Gastroenterol 2015;66:75. [DOI: 10.4166/kjg.2015.66.2.75] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
38 Matsuo Y, Kido Y, Akada J, Shiota S, Binh TT, Trang TTH, Dung HDQ, Tung PH, Tri TD, Thuan NPM, Tam LQ, Nam BC, Khien VV, Yamaoka Y. Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody. World J Gastroenterol 2017; 23(1): 48-59 [PMID: 28104980 DOI: 10.3748/wjg.v23.i1.48] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
39 Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013;7:35-40. [PMID: 23265147 DOI: 10.1586/egh.12.67] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
40 Zhao Z, Li Y, Liu S, Fu W. Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Tumour Biol. 2014;35:12217-12224. [PMID: 25168369 DOI: 10.1007/s13277-014-2530-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
41 Kodama M, Okimoto T, Mizukami K, Fukuda K, Ogawa R, Okamoto K, Matsunari O, Kawahara Y, Hirashita Y, Murakami K. Differences in Helicobacter pylori and CagA antibody changes after eradication between subjects developing and not developing gastric cancer. J Clin Biochem Nutr 2019;65:71-5. [PMID: 31379417 DOI: 10.3164/jcbn.19-30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]